[144] CELESTICA INC SEC Filing

Rhea-AI Filing Summary

Celestica Inc. is the issuer in a Form 144 notice covering planned insider sales of common shares. The person for whose account the securities are to be sold intends to sell 2,724 common shares and 948 common shares through Canaccord Genuity on the NYSE, with listed aggregate market values of 765,416.76 and 266,378.52, respectively.

The shares were recently acquired through restricted share unit vesting from Celestica Inc. on 02/02/2026 and 02/04/2026 in blocks of 1,602, 1,122, 538 and 410 common shares. The notice states that 115,036,621 common shares of the issuer are outstanding and includes a representation that the seller does not know of any undisclosed material adverse information about Celestica’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Canaccord Genuity 40 Temperance Street Suite 2100 Toronto A6 M5H 0B4	2724	765416.76	115036621	02/02/2026	NYSE
Common Shares	Canaccord Genuity 40 Temperance Street Suite 2100 Toronto A6 M5H 0B4	948	266378.52	115036621	02/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Shares	02/02/2026	Restricted share unit vesting	Celestica Inc.			1602	02/02/2026	N/A
Common Shares	02/02/2026	Restricted share unit vesting	Celestica Inc.			1122	02/02/2026	N/A
Common Shares	02/04/2026	Restricted share unit vesting	Celestica Inc.			538	02/04/2026	N/A
Common Shares	02/04/2026	Restricted share unit vesting	Celestica Inc.			410	02/04/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)